Bupropion Hydrochloride Tablet, Extended Release
Product Images NDC 68071-5328

2 FDA label images from Nucare Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 68071-5328). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bupropion-structure.jpg (Bupropion Structure)

Bupropion-structure.jpg (Bupropion Structure)
Chemical structure of bupropion hydrochloride showing a chlorophenyl group connected to a keto and amine functional group with three methyl groups attached to the nitrogen, along with hydrochloride indicated separately.*
FDA Label Image

Jpg (68071 5328 3)

Jpg (68071 5328 3)
Label for Bupropion hydrochloride 150 mg extended-release oral tablets by NuCare Pharmaceuticals Inc. The package contains 30 E-R tablets. The label includes the NDC number 68071-5328-3 and states each tablet contains 150 mg Bupropion Hydrochloride USP. Instructions indicate to take one tablet every 12 hours. Storage is at controlled room temperature of 68-77°F. The label has warnings about keeping out of reach of children and advises to see manufacturer's label for full ingredients.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.